Dupixent® has been granted FDA approval as the exclusive therapy indicated for pediatric patients over the age of 1 diagnosed with eosinophilic esophagitis (EoE).

Bupropion Hydrochloride is a tiny molecule drug that targets multiple functions, including dopamine transporter (DAT), adrenergic receptor, and CYP2D6.

Orion Presents New Insights from Phase II CYPIDES Trial on ODM-208 at 2024 ASCO Symposium.

Phentermine, a small molecular compound, targets the TAAR1 receptor as an agonist and serves as an appetite suppressant for obesity management.

Lorazepam, a minute molecular compound, acts as an agonist that targets the GABAA receptor.

Cetirizine Hydrochloride, a minuscule molecule with a multifaceted pharmacological profile, operates as a potent and selective H1 receptor antagonist.

Claritin (loratadine) is an oral, second-generation antihistamine used for treating allergies like hay fever and hives.

WELLBUTRIN® (bupropion hydrochloride) is an aminoketone antidepressant indicated for the treatment of major depressive disorder (MDD).

BuSpar® (buspirone hydrochloride tablets, USP) is a medication used for the management of anxiety disorders or the short-term relief of anxiety symptoms.

Fluoxetine Hydrochloride, also known by the trade name PROZAC®, is a drug that works as a selective serotonin reuptake inhibitor (SSRI).

Spironolactone, also known by the trade name ALDACTONE®, is a drug that works as a mineralocorticoid receptor (MR) antagonist.

Promethazine, also known by the trade name PHENERGAN®, is a drug that works as an H1 receptor antagonist.